70 related articles for article (PubMed ID: 21178269)
1. Evaluation of human neutrophil peptide-1, -2 and -3 as serum markers for colorectal cancer.
van den Broek I; Sparidans RW; Engwegen JY; Cats A; Depla AC; Schellens JH; Beijnen JH
Cancer Biomark; 2010; 7(2):109-15. PubMed ID: 21178269
[TBL] [Abstract][Full Text] [Related]
2. Human neutrophil peptides 1, 2 and 3 (HNP 1-3): elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastasis.
Kemik O; Kemik AS; Sumer A; Begenik H; Purisa S; Tuzun S
Hum Exp Toxicol; 2013 Feb; 32(2):167-71. PubMed ID: 21669914
[TBL] [Abstract][Full Text] [Related]
3. Detection of colorectal disease by stool defensin assay: an exploratory study.
Zou H; Harrington JJ; Sugumar A; Klatt KK; Smyrk TC; Ahlquist DA
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):865-8. PubMed ID: 17531545
[TBL] [Abstract][Full Text] [Related]
4. Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1085-92. PubMed ID: 20356805
[TBL] [Abstract][Full Text] [Related]
5. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study.
Albrethsen J; Bøgebo R; Gammeltoft S; Olsen J; Winther B; Raskov H
BMC Cancer; 2005 Jan; 5():8. PubMed ID: 15656915
[TBL] [Abstract][Full Text] [Related]
6. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
Zhao Z; Xiao Y; Elson P; Tan H; Plummer SJ; Berk M; Aung PP; Lavery IC; Achkar JP; Li L; Casey G; Xu Y
J Clin Oncol; 2007 Jul; 25(19):2696-701. PubMed ID: 17602074
[TBL] [Abstract][Full Text] [Related]
7. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
8. Elevation of human alpha-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium.
Zhou L; Beuerman RW; Ang LP; Chan CM; Li SF; Chew FT; Tan DT
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2077-86. PubMed ID: 19168894
[TBL] [Abstract][Full Text] [Related]
9. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection.
Shiomi K; Nakazato M; Ihi T; Kangawa K; Matsuo H; Matsukura S
Biochem Biophys Res Commun; 1993 Sep; 195(3):1336-44. PubMed ID: 8216266
[TBL] [Abstract][Full Text] [Related]
10. Patients with sporadic colorectal cancer or advanced adenomatous polyp have elevated anti-JC virus antibody titer in comparison with healthy controls: a cross-sectional study.
Niv Y; Vilkin A; Levi Z
J Clin Gastroenterol; 2010 Aug; 44(7):489-94. PubMed ID: 20421810
[TBL] [Abstract][Full Text] [Related]
11. Detection of individual human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in unfractionated gingival crevicular fluid--a MALDI-MS approach.
Lundy FT; Orr DF; Shaw C; Lamey PJ; Linden GJ
Mol Immunol; 2005 Mar; 42(5):575-9. PubMed ID: 15607816
[TBL] [Abstract][Full Text] [Related]
12. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
13. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
14. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
15. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer.
Albrethsen J; Møller CH; Olsen J; Raskov H; Gammeltoft S
Eur J Cancer; 2006 Nov; 42(17):3057-64. PubMed ID: 17015013
[TBL] [Abstract][Full Text] [Related]
16. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
[TBL] [Abstract][Full Text] [Related]
18. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose metabolism in colorectal cancer.
Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
[TBL] [Abstract][Full Text] [Related]
20. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
